SHOCKWAVE MEDICAL, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 330 USD | +0.31% |
|
+0.30% | +73.17% |
| 11/04 | Health Care Slips on Risk Bias -- Health Care Roundup | DJ |
| 09/04 | CL King Downgrades ShockWave Medical to Neutral From Buy, Cuts Price Target to $335 From $368 | MT |
Chart calendar Shockwave Medical, Inc.
d0e5c927ec79c8664154.E-qpdWnOT-TfN7ZbfhAsHSQxNU-F8dOL23pb9ln-HvQ.VJPjPTioENzocOkSEEdEaxBVcja3gOvIoQNisWqJfY1BqOozBoAugeZw-w~cd9bb8c6112ba0a995c2672d2e44c0dc
Upcoming events on Shockwave Medical, Inc.
Past events on Shockwave Medical, Inc.
| 16/02/2024 03:00 am | Q4 2023 Earnings Call |
| 16/02/2024 02:33 am | Q4 2023 Earnings Release |
| 10/01/2024 09:00 pm | JPMorgan Healthcare Conference |
| 30/11/2023 12:00 am | Piper Sandler Healthcare Conference |
| 15/11/2023 07:15 pm | Wolfe Research Healthcare Conference |
| 07/11/2023 03:00 am | Q3 2023 Earnings Call |
| 07/11/2023 02:33 am | Q3 2023 Earnings Release |
| 27/10/2023 01:15 am | Transcatheter Cardiovascular Therapeutics Scientific Symposium - Yousif Ahmad, M.D |
| 26/10/2023 11:12 pm | Transcatheter Cardiovascular Therapeutics Scientific Symposium - Neel Butala |
| 25/10/2023 11:30 pm | Transcatheter Cardiovascular Therapeutics Scientific Symposium - James C. Spratt |
| 25/10/2023 02:30 am | Transcatheter Cardiovascular Therapeutics Scientific Symposium - Gregg W. Stone |
| 24/10/2023 01:30 am | Investor Meeting |
| 23/10/2023 11:00 pm | Transcatheter Cardiovascular Therapeutics Scientific Symposium - Ashok Seth |
| 12/09/2023 11:45 pm | Morgan Stanley Global Healthcare Conference - Fireside Chat |
| 06/09/2023 11:00 pm | Wells Fargo Healthcare Conference - Fireside Chat |
| 10/08/2023 01:00 am | Canaccord Genuity Growth Conference |
| 08/08/2023 02:00 am | Q2 2023 Earnings Call |
| 08/08/2023 01:31 am | Q2 2023 Earnings Release |
| 13/06/2023 08:30 pm | Annual General Meeting |
| 10/05/2023 11:50 pm | Bank of America Healthcare Conference |
Annual results
| Fiscal Period | December | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 42,9 42,1 2.02% | 67,8 65,4 3.58% | 237 228 3.88% | 490 489 0.12% | 730 727 0.47% | 921 |
|
EBITDA Million USD | Released Forecast Spread | -46,9 -48,4 3.23% | -53,5 -54,3 1.47% | 30,0 17,2 74.72% | 174 170 2.16% | 243 198 22.74% | 263 |
|
EBIT Million USD | Released Forecast Spread | -51,8 -51,2 -1.16% | -65,7 -64,1 -2.45% | -0,87 -10,9 92.02% | 124 121 2.68% | 159 159 0% | 212 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -51,0 -51,3 0.5% | -65,6 -63,8 -2.85% | -8,84 -18,4 52.02% | 121 115 5.02% | 174 162 7.83% | 234 |
|
Net income Million USD | Released Forecast Spread | -51,1 -51,1 -0.07% | -65,7 -64,1 -2.45% | -9,14 -18,6 50.87% | 216 113 91.03% | 147 137 7.22% | 187 |
|
EPS USD | Released Forecast Spread | -2,14 -1,79 -19.55% | -1,99 -1,95 -1.84% | -0,26 -0,53 50.76% | 5,70 3,00 89.81% | 3,85 3,60 7.09% | 4,83 |
| Announcement Date | 13/02/20 | 17/02/21 | 17/02/22 | 16/02/23 | 15/02/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 84,2 75,4 11.6% | 93,6 86,4 8.36% | 121 108 12.31% | 131 124 6.09% | 144 143 0.69% | 161 147 9.22% | 180 174 3.67% | 186 185 0.71% | 203 199 1.77% | 208 | 227 | 232 | 254 | 255 |
|
EBITDA Million USD | Released Forecast Spread | 23,1 12,3 88.45% | 25,8 16,5 56.58% | 41,7 29,2 43.01% | 49,8 34,2 45.62% | 56,6 53,6 5.7% | 57,5 43,8 31.34% | 50,9 48,8 4.32% | 65,0 42,9 51.67% | 68,2 52,6 29.52% | 53,9 | 65,2 | 69,8 | 79,8 | 76,5 |
|
EBIT Million USD | Released Forecast Spread | 14,0 3,91 257.82% | 15,4 9,31 65.19% | 29,6 19,3 53.18% | 36,8 28,9 27.01% | 42,4 39,3 8.03% | 39,8 35,8 11.3% | 32,4 39,8 -18.6% | 43,6 36,6 19.08% | 43,3 43,2 0.26% | 39,4 | 50,7 | 53,8 | 64,4 | 58,4 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 13,0 3,40 283.83% | 14,7 9,45 55.7% | 26,3 18,8 39.83% | 35,1 27,9 25.69% | 44,7 38,9 14.67% | 40,7 35,8 13.75% | 33,0 40,0 -17.46% | 45,1 36,5 23.62% | 55,5 42,8 29.67% | 48,1 | 58,4 | 60,6 | 71,7 | 65,3 |
|
Net income Million USD | Released Forecast Spread | 12,9 3,39 281.28% | 14,5 7,12 104.07% | 25,6 17,0 50.25% | 35,0 26,2 33.61% | 141 38,0 270.4% | 39,1 31,2 25.37% | 28,9 33,2 -13.01% | 35,0 30,6 14.46% | 44,3 34,4 28.89% | 37,4 | 46,3 | 49,0 | 57,6 | 54,6 |
|
EPS USD | Released Forecast Spread | 0,34 0,09 286.36% | 0,39 0,19 105.26% | 0,68 0,45 51.11% | 0,92 0,68 34.96% | 3,71 1,01 266.81% | 1,03 0,81 26.39% | 0,76 0,87 -12.2% | 0,92 0,80 15.39% | 1,16 0,90 29.6% | 0,97 | 1,20 | 1,26 | 1,48 | 1,41 |
| Announcement Date | 17/02/22 | 09/05/22 | 08/08/22 | 07/11/22 | 16/02/23 | 08/05/23 | 07/08/23 | 06/11/23 | 15/02/24 | - | - | - | - | - |
| 29/04/2024 | SHENZHEN YHLO BIOTECH CO., LTD.: Q1 2024 Earnings Release (Projected) |
| 30/04/2024 | INARI MEDICAL, INC.: Q1 2024 Earnings Release |
| 02/05/2024 | IRADIMED CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 04:30 pm | NOVOCURE LIMITED: Q1 2024 Earnings Release |
| 06/05/2024 | SHOCKWAVE MEDICAL, INC.: Q1 2024 Earnings Release |
| 07/05/2024 01:39 am | SI-BONE, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | MASIMO CORPORATION: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | TREACE MEDICAL CONCEPTS, INC.: Q1 2024 Earnings Release |
| 08/05/2024 01:35 am | PENUMBRA, INC.: Q1 2024 Earnings Release |
| 08/05/2024 | CHEMOMETEC A/S: Q3 2024 Earnings Release |
Past sector events for Shockwave Medical, Inc.
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- SWAV Stock
- Calendar Shockwave Medical, Inc.
